C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)

Clinical trial NCT00921752 · COMPLETED

Trial details

NCT number: NCT00921752
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Cardiovascular Risk

Start date: 2009-05-01
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.